Adrian Harel/LinkedIn
Jun 17, 2026, 16:29
Adrian Harel: Medicortex’s Review on Diagnostic Biomarkers of Ischemic Stroke Is Live Now
Adrian Harel, Founder and CEO at Medicortex Finland Oyj, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Frontiers, adding:
”Medicortex’s review article on diagnostic biomarkers of ischemic stroke was just published.”
Title: Diagnostic biomarkers of ischemic stroke: strengths and limitations across blood, urine, and saliva
Authors: Begüm Utz, Pihla Miettinen, Ivette Bañuelos-Cabrera, Leonardo Lara-Valderrábano, Lasse Välimaa, Adrian Harel

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments